Clinical Study of Radiotherapy Combined With Camrelizumab and Apatinib in the Treatment of Liver Cancer Patients .

Status:
NOT_YET_RECRUITING

Trial end date:
2026-12-30

Target enrollment:

Participant gender:

Clinical study of radiotherapy combined with Camrelizumab and Apatinib in the treatment of liver cancer patients with VP4.

PHASE2

Beijing Tsinghua Chang Gung Hospital

apatinib
camrelizumab